GENEO Capital Entrepreneur supports GBNA Santé in its acquisition of Francheville Périgord Santé
Paris, 03/10/2023
GENEO Capital Entrepreneur supported GBNA Santé in the acquisition of three facilities from the Francheville Perigord Santé group, strengthening GBNA's position as a leading hospital group in the Nouvelle-Aquitaine region, with a total of 12 healthcare facilities. This acquisition, announced in June and formally completed in September, was partly financed by a capital increase in which GENEO Capital Entrepreneur, which has been supporting GBNA since 2021, participated along with UI Investissement.
For GBNA Santé, a predominantly family-owned group, this transaction marks a significant milestone in the region's economic landscape. It testifies to its strong regional roots, affirming its proximity to healthcare players, local institutions, hospital communities and patients.
GENEO Capital Entrepreneur is convinced that this transaction paves the way for sustained growth for both entities, and will enable GBNA Santé to pursue its development strategy by offering a diversified range of care services with a high level of expertise in the region. As a long-term investment company convinced that external growth is a valuable complement to organic growth, GENEO Capital is doubling its support for the company through this reinvestment. In total, the 20 companies invested by GENEO Capital since March 2019 have made 47 acquisitions.
Marc Dupuy, Managing Partner, GENEO Capital Entrepreneur, comments: "We are proud to support GBNA in its long-term development projects. This emblematic transaction underlines the strength and attractiveness of our "evergreen" investment model. The "evergreen" character offers us the ability to reinvest regularly, without time constraints, to enable dynamic companies to seize opportunities with agility as they arise. GENEO Capital Entrepreneur renews its commitment and confidence in GBNA by increasing its investment from €7.5 million to €8 million".
* * * *
About GENEO Capital Entrepreneur :
GENEO Capital Entrepreneur's raison d'être is to provide the real economy with positive finance that reconciles performance and meaning.
Designed to unlock the potential for value creation, job creation and impact of SMEs and ETIs, GENEO Capital Entrepreneur has nearly 600 million euros at its disposal. It manages in particular :
- GENEO Capital is an evergreen investment company with a 99-year lifespan, majority-owned by families and entrepreneurs. GENEO provides tailor-made capital that adapts to the pace of each company, offering responsiveness and flexibility. Its resources increase regularly as GENEO and the companies it invests grow.
- The GENEO Mezzanine fund: a positive-impact mezzanine fund for ETIs and large SMEs, with a specialized impact transformation team. This fund makes it possible to provide real quasi-equity (not counted in debt ratios) without opening up companies' capital, and to support them in their development and impact disruption while offering them significant financial incentives.
As a business partner, GENEO mobilizes its teams and specialized business partners (external growth, positive impact, digital and innovation) to support the execution of structuring, growth and transformation projects. It also boasts a platform of over 140 independent experts and a community of more than 220 families and entrepreneurs, providing a unique opportunity to share experiences and build a business network unmatched in France. The terms of this operational support are tailored to the specific needs of each company, and formalized jointly by the GENEO team, the management team and the company's other shareholders in a "Carnet de croissance".
Passionate about those who make, create and want to move the lines, the only ambition of the GENEO team is to bring the ambition of each entrepreneur to the top.
At GENEO, when we invest, we invest!
For more information: www.geneocapitalentrepreneur.com
https://twitter.com/GeneoCapital
https://www.linkedin.com/company/geneo-capital-entrepreneur
https://www.youtube.com/channel/UChZh_aqfqG-v9ANGWlLY2Tw
Press contacts :
Verbatee Agency:
Cyrille Lachèvre 06 20 42 12 08 - c.lachevre@verbatee.com
Barbara Baudier 06 68 53 28 49 - b.baudier@verbatee.com